Pyruvate dehydrogenase complex (PDC) deficiency is a mitochondrial disorder arising from loss-of-function alterations in the multienzyme assembly that converts glycolytic pyruvate into acetyl-CoA, the ...
Cancer cells often reprogramme energy metabolism to support rapid proliferation and survival under stress. Central to this shift is the pyruvate dehydrogenase complex (PDC), a mitochondrial ...
Following an August 2025 CRL that raised no safety or manufacturing concerns, Saol provided additional survival analyses of existing clinical data to address FDA requirements without embarking on a ...
The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for SL1009 (sodium dichloroacetate oral solution) for the treatment of pyruvate dehydrogenase complex ...
Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced the resubmission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for SL1009 ...
A new method has enabled the natural structure of particularly large and complex enzymes to be revealed. Scientists at Martin Luther University Halle-Wittenberg (MLU) and TU Berlin have published ...
The pyruvate dehydrogenase complex consists of many different enzymes (marked in different colours). Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results